10.1371/journal.ppat.1007059 182 RouaultT
For those without pre-existing pancreatic disease, GLP-1 medications are considered to have a favorable safety profile, with pancreatitis being rare and not definitively proven to increase in well-controlled trial data. David Cutler, MD Cutler said that for most people, the absolute risk of experiencing pancreatitis will be very low
A 79 year old female living in a long term care facility was diagnosed with a UTI
Trump Is Shattering the Illusion of the West Amitav Acharya , a distinguished professor at American Universitys School of International Service
Febuxostat compared with allopurinol in patients with hyperuricemia and gout
The claims made on a bottle or a website are often not backed by rigorous, large-scale, placebo-controlled human trials